Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yunnan Baiyao Capsule for Functional Recovery After Osteoporotic Vertebral Compression Fracture Surgery
ChiCTR2600129944Phase 4Not yet recruiting
- Sponsor
- Shenzhen University General Hospital
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in vertebral compression fracture (VCF) comparing Yunnan Baiyao capsule + basic treatment with Placebo capsule + basic treatment (2 arms). Primary endpoint: Change in Oswestry Disability Index score from baseline at postoperative week 12. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
Yunnan Baiyao
03
Conditions
vertebral compression fracture (VCF)
Beyond the preview
Go deeper on ChiCTR2600129944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600129944.